Afatinib in NSCLC harbouring EGFR mutations

Lancet Oncol. 2014 Apr;15(4):e148-9. doi: 10.1016/S1470-2045(13)70402-9.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Asian People / genetics*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • ErbB Receptors / genetics*
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male
  • Mutation*
  • Protein Kinase Inhibitors / therapeutic use*
  • Quinazolines / therapeutic use*

Substances

  • Protein Kinase Inhibitors
  • Quinazolines
  • ErbB Receptors